Concepedia
Statistics
Publications
14
Citations
1.5K
H-Index
Active since
1987
Affiliations
Chugai Pharma (United States)(Current)
Mochida Pharmaceutical (Japan)
Kyoto Prefectural University of Medicine
Kyushu University
The University of Tokyo
Tetsuro Orita is an author at Chugai Pharma (United States) specializing in life sciences, gene expression, and molecular biology.
Publications per year
1987–2010
Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell Line
Katsunori Nakano, Takakazu Mizuno, Yoshihiro Sowa et al. · Journal of Biological Chemistry · 1997 · 396 citations · Full text
Medicine, Molecular Biology, Oncology +11
Histone Deacetylase Inhibitor Activates the WAF1/Cip1 Gene Promoter through the Sp1 Sites
Yoshihiro Sowa, Tetsuro Orita, Sachie Minamikawa et al. · Biochemical and Biophysical Research Communications · 1997 · 290 citations
Life Sciences, Genetics, Molecular Biology +12
Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Yoshihiro Sowa, Tetsuro Orita, Sachie Minamikawa-Hiranabe et al. · PubMed · 1999 · 148 citations
Life Sciences, Cancer Biology, Molecular Biology +17
Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1
Naoki Kubota, Tetsuro Orita, Kunihiro Hattori et al. · The Journal of Biochemistry · 1990 · 120 citations
Life Sciences, Biochemistry, Immunology +10
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
Kiyotaka Nakano, Tetsuro Orita, Jun‐ichi Nezu et al. · Biochemical and Biophysical Research Communications · 2008 · 111 citations
Medicine, Oncology, Pharmacology +14
1–5 of 14